Global Head of Immunology Early Development
In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicines. Together, we create a culture defined by curiosity, responsibility and humility, where our talented people are empowered and inspired to bring forward extraordinary life-changing innovation at speed.
You are a member of the Immunology leadership team, reporting to the pRED Global Head of Immunology. The focus of Immunology Early Development is to advance early clinical immunology development programs from preclinical studies through proof of concept and dose ranging phase 2 studies. This role is a key enabler in delivering on the clinical pipeline as well as the overall ambitions of the organization.
You are responsible for the strategy of the immunology early clinical development portfolio and pipeline, and mentor, develop, guide, and serve as the leader for the clinical scientists, medical directors, and project team leaders.
You work with the clinical phase project teams to ensure that clinical and clinical biomarker development plans, objectives, and deliverables are consistently accomplished on-time and on-target for assigned projects.
You chair the Development Review Committee and provide key feedback and guidance on project strategy and plans and represent Immunology on the pRED Early Strategic Portfolio Committee.
You serve as a core member of the pRED Immunology leadership team to build disease area strategy, discovery and development strategy, and operational excellence
You explore and implement collaborations with industry and academia to increase understanding of disease biology, facilitate the prosecution of portfolio in early clinical development and build our clinical portfolio.
You liaise with Roche Pharma Late Stage Development, Global Product Strategy, Regulatory and Clinical Operations, as well as other Roche Research and Discovery Units in discussions around disease strategy, discovery and development strategy, and operational excellence.
With a MD or MD/PhD, you bring at least 5-10 years of experience in pharmaceutical research and development with a broad understanding of immune-mediated diseases, clinical trial design and methodology as well as biomarkers and diagnostics.
You can ideally demonstrate a solid track record of successfully translating molecules from discovery into the clinical setting as well as an understanding of regulatory, payer, and commercial issues in the pharmaceutical industry.
Your leadership has been demonstrated by an ability to work with peers across a matrix organization to deliver on common goals. You inspire people to think bold, to innovate, collaborate and create great outcomes that matter for our patients and customers.
You are a leader who creates and communicates a clear strategic vision for the team and the organization. This includes monitoring and reassessing strategic priorities, articulating long-term opportunities/threats, evaluating options, and building clear paths to success
You understand how to make difficult decisions and will be able to focus on key priorities and delivery toward goals and have the ability to empower teams, inspiring and creating a strong sense of team spirit in the organization. You help everyone on your team to build the skills and mindset they need to succeed.
Roche commits to recognising talent and aptitude. We prioritise encouraging and supporting our employees on their personal journeys by providing a safe, creative space to help them reflect, make decisions and grow in their career.
We are confident that we find the most innovative solutions by gaining different perspectives, asking and answering hard questions, and challenging the status quo. Roche embraces diversity and equal opportunity in a serious yet enthusiastic way; we are devoted to building a team that represents a range of backgrounds, perspectives, and skills. The more inclusive we are, the better our work will be.
At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.
Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 10,700 employees from over 100 countries come together at our Basel/Kaiseraugst site, which is one of Roche`s largest sites. Read more.
Besides extensive development and training opportunities, we offer flexible working options, 18 weeks of maternity leave and 10 weeks of gender independent partnership leave. Our employees also benefit from multiple services on site such as child-care facilities, medical services, restaurants and cafeterias, as well as various employee events.
We believe in the power of diversity and inclusion, and strive to identify and create opportunities that enable all people to bring their unique selves to Roche.
Roche is an Equal Opportunity Employer.
